{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "19475447", "DateCompleted": {"Year": "2009", "Month": "08", "Day": "11"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "20"}, "Article": {"ArticleDate": [{"Year": "2009", "Month": "05", "Day": "28"}], "Language": ["eng"], "ELocationID": ["10.1007/s00284-009-9416-9"], "Journal": {"ISSN": "1432-0991", "JournalIssue": {"Volume": "59", "Issue": "2", "PubDate": {"Year": "2009", "Month": "Aug"}}, "Title": "Current microbiology", "ISOAbbreviation": "Curr Microbiol"}, "ArticleTitle": "Inhibitory and resistance-modifying potential of plant-based alkaloids against methicillin-resistant Staphylococcus aureus (MRSA).", "Pagination": {"StartPage": "181", "EndPage": "186", "MedlinePgn": "181-6"}, "Abstract": {"AbstractText": ["Increased prevalence of methicillin-resistant Staphylococcus aureus (MRSA) has become a major threat to the health sector worldwide due to their virulence, limited therapeutic options and their distribution in both hospital and community settings. Discovery and development of new anti-MRSA agents as alternatives to the very few antibiotics left in the armamentarium are, thus, urgently required. Recently, an efflux mechanism in MRSA has been identified as one of the main contributors of resistance towards various structurally unrelated antibiotics. The potential of reserpine (a phytoalkaloid) as efflux pump inhibitor (EPI) against various microbes remains limited as the concentration needed for inhibition is toxic to humans. This study therefore aimed to evaluate 13 alkaloid compounds as potential inhibitory agents and/or potential EPIs against a panel of three MRSA isolates which not only differ in their susceptibility to vancomycin (amongst the last drugs available to treat serious MRSA infection), but also exhibited active efflux activity. Results indicated berberine's moderate inhibitiory activity against two MRSA isolates scoring a minimum inhibitory concentration (MIC) value of 125 microg/ml. Notable efflux inhibitory activity (ranging from two- to eightfold Ethidium Bromide MIC reduction) meanwhile was detected from quinine, piperine and harmaline using reserpine as the positive control. Findings from this study support the opinion that a vast number of potential phytocompounds with pharmacological potential await discovery. Therapeutic application of these compounds, however, warrants further investigation to ascertain their pharmacodynamics and safety aspects."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Antimicrobial Laboratory, Medicinal Plants Programme, Forest Biotechnology Division, Forest Research Institute Malaysia, Kepong, Selangor, Malaysia. mastura@frim.gov.my"}], "Identifier": [], "LastName": "Mohtar", "ForeName": "Mastura", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Johari", "ForeName": "Saiful Azmi", "Initials": "SA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Li", "ForeName": "Abdul Rashid", "Initials": "AR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Isa", "ForeName": "Mazurah Mohamed", "Initials": "MM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Mustafa", "ForeName": "Shuhaimi", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ali", "ForeName": "Abdul Manaf", "Initials": "AM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Basri", "ForeName": "Dayang Fredalina", "Initials": "DF"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Curr Microbiol", "NlmUniqueID": "7808448", "ISSNLinking": "0343-8651"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}], "MeshHeadingList": [{"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": ["drug effects"], "DescriptorName": "Drug Resistance, Bacterial"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Methicillin-Resistant Staphylococcus aureus"}, {"QualifierName": [], "DescriptorName": "Microbial Sensitivity Tests"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Arch Intern Med. 1998 Nov 9;158(20):2225-34", "ArticleIdList": ["9818802"]}, {"Citation": "Med Toxicol Adverse Drug Exp. 1988 Sep-Oct;3(5):376-86", "ArticleIdList": ["3057327"]}, {"Citation": "J Antimicrob Chemother. 2005 Jul;56(1):20-51", "ArticleIdList": ["15914491"]}, {"Citation": "Clin Microbiol Rev. 1999 Oct;12(4):564-82", "ArticleIdList": ["10515903"]}, {"Citation": "Nat Prod Rep. 2004 Apr;21(2):263-77", "ArticleIdList": ["15042149"]}, {"Citation": "J Photochem Photobiol B. 1998 Jan;42(1):1-11", "ArticleIdList": ["9491591"]}, {"Citation": "J Biol Chem. 1991 Aug 15;266(23):15340-7", "ArticleIdList": ["1831202"]}, {"Citation": "Todays Surg Nurse. 1998 Mar-Apr;20(2):20-4", "ArticleIdList": ["10026625"]}, {"Citation": "Antimicrob Agents Chemother. 2006 Feb;50(2):810-2", "ArticleIdList": ["16436753"]}, {"Citation": "J Basic Microbiol. 2008 Aug;48(4):245-51", "ArticleIdList": ["18720500"]}, {"Citation": "Curr Med Chem. 2001 Dec;8(14):1699-711", "ArticleIdList": ["11562289"]}, {"Citation": "J Antimicrob Chemother. 1997 Jul;40(1):135-6", "ArticleIdList": ["9249217"]}, {"Citation": "J Clin Invest. 2004 Dec;114(12):1693-6", "ArticleIdList": ["15599392"]}, {"Citation": "J Antimicrob Chemother. 2007 Jun;59(6):1247-60", "ArticleIdList": ["17145734"]}, {"Citation": "J Bacteriol. 1997 Apr;179(8):2557-66", "ArticleIdList": ["9098053"]}, {"Citation": "J Nat Prod. 2005 May;68(5):711-5", "ArticleIdList": ["15921415"]}, {"Citation": "Evid Based Complement Alternat Med. 2006 Mar;3(1):39-48", "ArticleIdList": ["16550222"]}, {"Citation": "J Antimicrob Chemother. 1991 Jan;27(1):71-9", "ArticleIdList": ["1828799"]}, {"Citation": "MMWR Morb Mortal Wkly Rep. 2002 Jul 5;51(26):565-7", "ArticleIdList": ["12139181"]}, {"Citation": "J Antimicrob Chemother. 2003 Jan;51(1):13-7", "ArticleIdList": ["12493782"]}, {"Citation": "J Biol Chem. 1991 Dec 25;266(36):24540-8", "ArticleIdList": ["1837024"]}, {"Citation": "FEBS Lett. 1995 Sep 4;371(2):119-22", "ArticleIdList": ["7672109"]}, {"Citation": "J Med Chem. 2001 Jan 18;44(2):261-8", "ArticleIdList": ["11170636"]}, {"Citation": "Infect Control Hosp Epidemiol. 2003 Jun;24(6):436-8", "ArticleIdList": ["12828321"]}, {"Citation": "Farmaco. 2005 Nov-Dec;60(11-12):874-83", "ArticleIdList": ["16243320"]}, {"Citation": "Phytochemistry. 2004 Dec;65(24):3249-54", "ArticleIdList": ["15561190"]}, {"Citation": "Antimicrob Agents Chemother. 2007 Sep;51(9):3235-9", "ArticleIdList": ["17576828"]}, {"Citation": "Microbiol Rev. 1996 Dec;60(4):575-608", "ArticleIdList": ["8987357"]}, {"Citation": "Planta Med. 1998 Dec;64(8):711-3", "ArticleIdList": ["9933989"]}]}], "History": [{"Year": "2008", "Month": "12", "Day": "16"}, {"Year": "2009", "Month": "4", "Day": "15"}, {"Year": "2009", "Month": "4", "Day": "7"}, {"Year": "2009", "Month": "5", "Day": "29", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "5", "Day": "29", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "8", "Day": "12", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["19475447", "10.1007/s00284-009-9416-9"]}}], "PubmedBookArticle": []}